Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Castration Medicine & Life Sciences
Survival Medicine & Life Sciences
Androgens Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Suramin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1977 2018

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies

Gravis, G., Boher, J. M., Chen, Y. H., Liu, G., Fizazi, K., Carducci, M. A., Oudard, S., Joly, F., Jarrard, D. M., Soulie, M., Eisenberger, M. J., Habibian, M., Dreicer, R., Garcia, J. A., Hussain, M. H. M., Kohli, M., Vogelzang, N. J., Picus, J., DiPaola, R. & Sweeney, C. Jan 1 2018 (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

Prostatic Neoplasms

Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: A randomized, multicenter, placebo-controlled clinical trial

Paller, C. J. , Zhou, X. C. , Heath, E. I. , Taplin, M. E. , Mayer, T. , Stein, M. N. , Bubley, G. J. , Pili, R. , Hudson, T. , Kakarla, R. , Abbas, M. M. , Anders, N. M. , Dowling, D. , King, S. , Bruns, A. B. , Wagner, W. D. , Drake, C. G. , Antonarakis, E. S. , Eisenberger, M. A. , Denmeade, S. R. & 3 others Rudek, M. A., Rosner, G. L. & Carducci, M. A. Jan 15 2018 In : Clinical Cancer Research. 24, 2, p. 306-315 10 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
Prostatic Neoplasms

Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)

Mehra, N., Dolling, D., Sumanasuriya, S., Christova, R., Pope, L., Carreira, S., Seed, G., Yuan, W., Goodall, J., Hall, E., Flohr, P., Boysen, G., Bianchini, D., Sartor, O., Eisenberger, M. A., Fizazi, K., Oudard, S., Chadjaa, M., Macé, S. & de Bono, J. S. Jan 1 2018 (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

Plasma Cells
Prostatic Neoplasms

Research in drug development for advanced prostate cancer

Eisenberger, M. Jan 1 2018 In : Clinical Advances in Hematology and Oncology. 16, 1, p. 42-44 3 p.

Research output: Contribution to journalComment/debate

Seven-month prostate-specific antigen is prognostic in metastatic hormone-sensitive prostate cancer treated with androgen deprivation with or without docetaxel

Harshman, L. C., Chen, Y. H., Liu, G., Carducci, M. A., Jarrard, D., Dreicer, R., Hahn, N., Garcia, J. A., Hussain, M., Shevrin, D., Eisenberger, M., Kohli, M., Plimack, E. R., Cooney, M., Vogelzang, N. J., Picus, J., Dipaola, R. & Sweeney, C. J. Feb 1 2018 In : Journal of Clinical Oncology. 36, 4, p. 376-382 7 p.

Research output: Contribution to journalArticle

Prostate-Specific Antigen
Prostatic Neoplasms